Guardian Pharmacy Services (GRDN) Income towards Parent Company (2023 - 2026)

Guardian Pharmacy Services has reported Income towards Parent Company for 4 years, with the latest figure at $13.5 million in Q1 2026.

• Quarterly Income towards Parent Company rose 46.06% year-over-year to $13.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $53.2 million (up 177.31% YoY) and the FY2025 annual result came in at $49.0 million, up 168.92% from the prior year.
• Income towards Parent Company retreated to $13.5 million in Q1 2026 per GRDN's latest filing, from $21.3 million in the prior quarter.
• Over five years, Income towards Parent Company peaked at $21.3 million in Q4 2025 and troughed at -$105.8 million in Q3 2024.
• A 4-year average of -$87909.1 and a median of $9.6 million in 2025 frame the typical range for Income towards Parent Company.
• The sharpest annual moves came in 2024 and 2025: Income towards Parent Company sank 1412.75% in 2024, then surged 109.07% in 2025.
• Over 4 years, Income towards Parent Company stood at $14.6 million in 2023, then retreated by 18.67% to $11.8 million in 2024, then soared by 79.59% to $21.3 million in 2025, then tumbled by 36.31% to $13.5 million in 2026.
• According to Business Quant data, Income towards Parent Company over the past three periods registered $13.5 million, $21.3 million, and $9.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.